UK markets closed

Arcutis Biotherapeutics, Inc. (ARQT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.24-0.36 (-4.74%)
At close: 04:00PM EDT
7.30 +0.06 (+0.83%)
After hours: 04:33PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-217,422
-262,140
-311,458
-206,356
-135,678
-
Depreciation & amortisation
1,516
1,521
934
454
122
-
Stock-based compensation
39,364
38,813
32,682
23,892
7,943
-
Change in working capital
-19,937
-23,501
-10,175
3,620
14,133
-
Accounts receivable
-24,385
-17,349
-8,458
0
0
-
Inventory
-4,696
-5,620
-7,514
0
0
-
Accounts payable
768
3,152
1,565
245
5,674
-
Other working capital
-198,662
-247,485
-280,998
-175,622
-113,354
-
Other non-cash items
4,410
4,390
32,555
309
333
-
Net cash provided by operating activities
-198,316
-247,057
-257,715
-174,627
-113,033
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-428
-23,283
-995
-321
-
Purchases of investments
-292,125
-225,840
-415,389
-292,508
-279,103
-
Sales/maturities of investments
336,255
406,500
351,473
217,550
97,600
-
Net cash used for investing activities
43,784
180,232
-87,199
-75,953
-181,824
-
Cash flows from financing activities
Common stock issued
260,583
98,901
176,047
207,490
297,002
-
Other financing activities
-
-
-2,187
-1,637
-
-1,401
Net cash used provided by (used for) financing activities
262,987
101,323
301,798
281,947
298,145
-
Net change in cash
108,384
34,448
-43,116
31,367
3,288
-
Cash at beginning of period
82,330
54,875
97,991
66,624
63,336
-
Cash at end of period
190,785
89,323
54,875
97,991
66,624
-
Free cash flow
Operating cash flow
-198,316
-247,057
-257,715
-174,627
-113,033
-
Capital expenditure
-
-428
-23,283
-995
-321
-
Free cash flow
-198,662
-247,485
-280,998
-175,622
-113,354
-